This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Köhler, T.
Right arrow Articles by Pechere, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Köhler, T.
Right arrow Articles by Pechere, J.-C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1999, p. 424-427, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Carbapenem Activities against Pseudomonas aeruginosa: Respective Contributions of OprD and Efflux Systems

Thilo Köhler,* Mehri Michea-Hamzehpour, Simone F. Epp, and Jean-Claude Pechere

Department of Genetics and Microbiology, Centre Médical Universitaire, CH-1211 Geneva 4, Switzerland

Received 12 June 1998/Returned for modification 2 October 1998/Accepted 24 November 1998

While meropenem MICs were strongly influenced by the presence or absence of the MexAB-OprM efflux pump in both OprD-proficient and -deficient strain backgrounds, MICs of imipenem and of ER-35786 remained unchanged, demonstrating that meropenem is a substrate of MexAB-OprM but not imipenem and ER-35786. In vitro, all three carbapenems selected loss of OprD as a first mechanism of resistance. However, in an OprD-deficient background, meropenem was able to select MexAB-OprM overproducers as a secondary resistance mechanism, while ER-35786 selected a mutant cross-resistant to sparfloxacin and cefpirome.


* Corresponding author. Mailing address: Department of Genetics and Microbiology, CMU, 9, av. de Champel, CH-1211 Geneva 4, Switzerland. Phone: 41-22-7025655. Fax: 41-22-7025702. E-mail: Thilo.Kohler{at}medecine.unige.ch.


Antimicrobial Agents and Chemotherapy, February 1999, p. 424-427, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lister, P. D., Wolter, D. J., Hanson, N. D. (2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 22: 582-610 [Abstract] [Full Text]  
  • Wolter, D. J., Black, J. A., Lister, P. D., Hanson, N. D. (2009). Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype. J Antimicrob Chemother 64: 294-300 [Abstract] [Full Text]  
  • Wolter, D. J., Khalaf, N., Robledo, I. E., Vazquez, G. J., Sante, M. I., Aquino, E. E., Goering, R. V., Hanson, N. D. (2009). Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 {beta}-Lactamases. Antimicrob. Agents Chemother. 53: 1660-1664 [Abstract] [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Kvist, M., Hancock, V., Klemm, P. (2008). Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation. Appl. Environ. Microbiol. 74: 7376-7382 [Abstract] [Full Text]  
  • Tanimoto, K., Tomita, H., Fujimoto, S., Okuzumi, K., Ike, Y. (2008). Fluoroquinolone Enhances the Mutation Frequency for Meropenem-Selected Carbapenem Resistance in Pseudomonas aeruginosa, but Use of the High-Potency Drug Doripenem Inhibits Mutant Formation. Antimicrob. Agents Chemother. 52: 3795-3800 [Abstract] [Full Text]  
  • Marchiaro, P., Ballerini, V., Spalding, T., Cera, G., Mussi, M. A., Moran-Barrio, J., Vila, A. J., Viale, A. M., Limansky, A. S. (2008). A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers. J Antimicrob Chemother 62: 336-344 [Abstract] [Full Text]  
  • Tseng, S.-P., Hsueh, P.-R., Tsai, J.-C., Teng, L.-J. (2007). Tn6001, a Transposon-Like Element Containing the blaVIM-3-Harboring Integron In450. Antimicrob. Agents Chemother. 51: 4187-4190 [Abstract] [Full Text]  
  • Maniati, M., Ikonomidis, A., Mantzana, P., Daponte, A., Maniatis, A. N., Pournaras, S. (2007). A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J Antimicrob Chemother 60: 132-135 [Abstract] [Full Text]  
  • Pournaras, S., Ikonomidis, A., Markogiannakis, A., Spanakis, N., Maniatis, A. N., Tsakris, A. (2007). Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J Med Microbiol 56: 66-70 [Abstract] [Full Text]  
  • Rodloff, A. C., Goldstein, E. J. C., Torres, A. (2006). Two decades of imipenem therapy. J Antimicrob Chemother 58: 916-929 [Abstract] [Full Text]  
  • Quale, J., Bratu, S., Gupta, J., Landman, D. (2006). Interplay of Efflux System, ampC, and oprD Expression in Carbapenem Resistance of Pseudomonas aeruginosa Clinical Isolates.. Antimicrob. Agents Chemother. 50: 1633-1641 [Abstract] [Full Text]  
  • Lister, P. D., Wolter, D. J., Wickman, P. A., Reisbig, M. D. (2006). Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs. J Antimicrob Chemother 57: 999-1003 [Abstract] [Full Text]  
  • Tam, V. H., Schilling, A. N., Neshat, S., Poole, K., Melnick, D. A., Coyle, E. A. (2005). Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 4920-4927 [Abstract] [Full Text]  
  • Wolter, D. J., Hanson, N. D., Lister, P. D. (2005). AmpC and OprD Are Not Involved in the Mechanism of Imipenem Hypersusceptibility among Pseudomonas aeruginosa Isolates Overexpressing the mexCD-oprJ Efflux Pump. Antimicrob. Agents Chemother. 49: 4763-4766 [Abstract] [Full Text]  
  • Marchiaro, P., Mussi, M. A., Ballerini, V., Pasteran, F., Viale, A. M., Vila, A. J., Limansky, A. S. (2005). Sensitive EDTA-Based Microbiological Assays for Detection of Metallo-{beta}-Lactamases in Nonfermentative Gram-Negative Bacteria. J. Clin. Microbiol. 43: 5648-5652 [Abstract] [Full Text]  
  • Ueda, Y., Kanazawa, K., Eguchi, K., Takemoto, K., Eriguchi, Y., Sunagawa, M. (2005). In Vitro and In Vivo Antibacterial Activities of SM-216601, a New Broad-Spectrum Parenteral Carbapenem. Antimicrob. Agents Chemother. 49: 4185-4196 [Abstract] [Full Text]  
  • Pournaras, S., Maniati, M., Spanakis, N., Ikonomidis, A., Tassios, P. T., Tsakris, A., Legakis, N. J., Maniatis, A. N. (2005). Spread of efflux pump-overexpressing, non-metallo-{beta}-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. J Antimicrob Chemother 56: 761-764 [Abstract] [Full Text]  
  • Pitout, J. D. D., Gregson, D. B., Poirel, L., McClure, J.-A., Le, P., Church, D. L. (2005). Detection of Pseudomonas aeruginosa Producing Metallo-{beta}-Lactamases in a Large Centralized Laboratory. J. Clin. Microbiol. 43: 3129-3135 [Abstract] [Full Text]  
  • Sobel, M. L., Neshat, S., Poole, K. (2005). Mutations in PA2491 (mexS) Promote MexT-Dependent mexEF-oprN Expression and Multidrug Resistance in a Clinical Strain of Pseudomonas aeruginosa. J. Bacteriol. 187: 1246-1253 [Abstract] [Full Text]  
  • Oliver, A., Levin, B. R., Juan, C., Baquero, F., Blazquez, J. (2004). Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections. Antimicrob. Agents Chemother. 48: 4226-4233 [Abstract] [Full Text]  
  • Mushtaq, S., Ge, Y., Livermore, D. M. (2004). Doripenem versus Pseudomonas aeruginosa In Vitro: Activity against Characterized Isolates, Mutants, and Transconjugants and Resistance Selection Potential. Antimicrob. Agents Chemother. 48: 3086-3092 [Abstract] [Full Text]  
  • Van Bambeke, F., Glupczynski, Y., Plesiat, P., Pechere, J. C., Tulkens, P. M. (2003). Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother 51: 1055-1065 [Full Text]  
  • Fernandez-Cuenca, F., Martinez-Martinez, L., Conejo, M{a} C., Ayala, J. A., Perea, E. J., Pascual, A. (2003). Relationship between {beta}-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 51: 565-574 [Abstract] [Full Text]  
  • Van Eldere, J. (2003). Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 51: 347-352 [Abstract] [Full Text]  
  • Epp, S. F., Köhler, T., Plésiat, P., Michéa-Hamzehpour, M., Frey, J., Pechère, J.-C. (2001). C-Terminal Region of Pseudomonas aeruginosa Outer Membrane Porin OprD Modulates Susceptibility to Meropenem. Antimicrob. Agents Chemother. 45: 1780-1787 [Abstract] [Full Text]  
  • Livermore, D. M. (2001). Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 47: 247-250 [Full Text]  
  • Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., Gotoh, N. (2001). Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates. Antimicrob. Agents Chemother. 45: 480-484 [Abstract] [Full Text]  
  • Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., Lomovskaya, O. (2000). Interplay between Efflux Pumps May Provide Either Additive or Multiplicative Effects on Drug Resistance. J. Bacteriol. 182: 3142-3150 [Abstract] [Full Text]  
  • Yang, Y., Testa, R. T., Bhachech, N., Rasmussen, B. A., Bush, K. (1999). Biochemical Characterization of Novel Tetrahydrofuranyl 1beta -Methylcarbapenems: Stability to Hydrolysis by Renal Dehydropeptidases and Bacterial beta -Lactamases, Binding to Penicillin Binding Proteins, and Permeability Properties. Antimicrob. Agents Chemother. 43: 2904-2909 [Abstract] [Full Text]  
  • Aires, J. R., Köhler, T., Nikaido, H., Plésiat, P. (1999). Involvement of an Active Efflux System in the Natural Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimicrob. Agents Chemother. 43: 2624-2628 [Abstract] [Full Text]  
  • Köhler, T., Epp, S. F., Curty, L. K., Pechère, J.-C. (1999). Characterization of MexT, the Regulator of the MexE-MexF-OprN Multidrug Efflux System of Pseudomonas aeruginosa. J. Bacteriol. 181: 6300-6305 [Abstract] [Full Text]